Chairs: Si Ming Man & Larisa Labzin
Role of iBALT in Tuberculosis (#2)
2:00 PM
Programmed cell death crosstalk in a monogenetic inflammatory disease (#3)
2:25 PM
ADS032, the first dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of infectious and inflammatory diseases (#4)
2:50 PM
MLKL mutation causes defective immune response during bacterial infection (#5)
3:05 PM
Probing the molecular basis of curbing TLR4-driven inflammatory responses (#6)
3:20 PM
IFNλ1 utilises interferon alpha/beta receptor 2 to induce signalling and anti-viral defence in lung epithelial cells (#7)
3:35 PM